Background and PurposeIn macrophages, transient receptor potential vanilloid 2 (TRPV2) channel contributes to various cellular processes such as cytokine production, differentiation, phagocytosis and migration. Due to a lack of selective pharmacological tools, its function in immunological processes is not well understood and the identification of novel and selective TRPV2 modulators is highly desirable.Experimental ApproachNovel and selective TRPV2 modulators were identified by screening a compound library using Ca2+ influx assays with human embryonic kidney 293 (HEK293) cells heterologously expressing rat TRPV2. Hits were further characterized and validated with Ca2+ influx and electrophysiological assays. Phagocytosis and migration of macrophages were analysed and the contribution of TRPV2 to the generation of Ca2+ microdomains was studied by total internal reflection fluorescence microscopy (TIRFM).Key ResultsThe compound IV2‐1, a dithiolane derivative (1,3‐dithiolan‐2‐ylidene)‐4‐methyl‐5‐phenylpentan‐2‐one), is a potent inhibitor of heterologously expressed TRPV2 channels (IC50 = 6.3 ± 0.7 μM) but does not modify TRPV1, TRPV3 or TRPV4 channels. IV2‐1 also inhibits TRPV2‐mediated Ca2+ influx in macrophages. IV2‐1 inhibits macrophage phagocytosis along with valdecoxib and after siRNA‐mediated knockdown. Moreover, TRPV2 inhibition inhibits lipopolysaccharide‐induced migration of macrophages whereas TRPV2 activation promotes migration. After activation, TRPV2 shapes Ca2+ microdomains predominantly at the margin of macrophages, which are important cellular regions to promote phagocytosis and migration.Conclusions and ImplicationsIV2‐1 is a novel TRPV2‐selective blocker and underline the role of TRPV2 in macrophage‐mediated phagocytosis and migration. Furthermore, we provide evidence that TRPV2 activation generates Ca2+ microdomains, which may be involved in phagocytosis and migration of macrophages.